SLC9A1 Binding mTOR Signaling Pathway-Derived Risk Score Predicting Survival and Immune in Clear Cell Renal Cell Carcinoma

Figure 7

Construction of a nomogram and verification that the risk score has a powerful survival prediction ability. Univariate (a) and multivariate (b) Cox regression analysis of the risk score and clinicopathological characteristics in ccRCC patients. (c) The development of a nomogram based on the risk score and clinicopathological characteristics. (d) The calibration curve of the nomogram in 1, 3, and 5 years. (e) Decision curve of the nomogram. (f) Compared with other clinicopathological features, the nomogram and the risk score exhibited the more powerful capacity for survival prediction.

(a)

(b)

(c)

(d)

(e)

(f)